ANNX
Price:
$5.175
Market Cap:
$551.62M
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain- barré syndrome; Phase II trial in patients with warm autoimmune hemolytic anemia; and Phase II clinical trial for Huntington's disease and amyotrophic lateral sclerosis. The company is also developin...[Read more]
Industry
Biotechnology
IPO Date
2020-07-24
Stock Exchange
NASDAQ
Ticker
ANNX
According to Annexon, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Annexon, Inc. over the last ten years is 0.21%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), ANNX's Dividend Yield was at its highest in in the December 2020 quarter at 0.65%. The Dividend Yield was at its lowest in in the March 2018 quarter at 0%.
Average
0.21%
Median
0%
Minimum
0%
Maximum
1.46%
Discovering the peaks and valleys of Annexon, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 1.46%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | -100.00% |
2020 | 1.46% | Infinity% |
2019 | 0% | 0% |
2018 | 0% | 0% |
The current Dividend Yield of Annexon, Inc. (ANNX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0.29%
10-year avg
0.21%
Annexon, Inc.’s Dividend Yield is less than Immix Biopharma, Inc. (0%), less than CNS Pharmaceuticals, Inc. (0%), less than Hepion Pharmaceuticals, Inc. (0%), less than Freeline Therapeutics Holdings plc (0%), less than AVROBIO, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Inozyme Pharma, Inc. (0%), less than VectivBio Holding AG (0%), less than IVERIC bio, Inc. (0%), less than Blueprint Medicines Corporation (0%), less than Amylyx Pharmaceuticals, Inc. (0%), less than Karuna Therapeutics, Inc. (0%), less than Arcus Biosciences, Inc. (0%), less than Cullinan Oncology, Inc. (0%), less than Structure Therapeutics Inc. (0%), less than Relay Therapeutics, Inc. (0%), less than Zura Bio Limited (0%), less than Icosavax, Inc. (0%), less than IN8bio, Inc. (0%), less than Wave Life Sciences Ltd. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $60.79M | |
0% | $6.28M | |
0% | $3.48M | |
0% | $28.28M | |
0% | $5.24M | |
0% | $1.27B | |
0% | $107.54M | |
0% | $108.79M | |
0% | $184.05M | |
0% | $1.06B | |
0% | $5.51B | |
0% | $5.65B | |
0% | $277.96M | |
0% | $12.60B | |
0% | $1.41B | |
0% | $678.93M | |
0% | $1.64B | |
0% | $718.91M | |
0% | $157.36M | |
0% | $769.04M | |
0% | $17.58M | |
0% | $2.04B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annexon, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Annexon, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Annexon, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Annexon, Inc. (ANNX)?
What is the highest Dividend Yield for Annexon, Inc. (ANNX)?
What is the 3-year average Dividend Yield for Annexon, Inc. (ANNX)?
What is the 5-year average Dividend Yield for Annexon, Inc. (ANNX)?
How does the current Dividend Yield for Annexon, Inc. (ANNX) compare to its historical average?